-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Asensus Surgical (NYSEAMERICAN:ASXC) Receives New Coverage From Analysts at Cantor Fitzgerald
Asensus Surgical (NYSEAMERICAN:ASXC) Receives New Coverage From Analysts at Cantor Fitzgerald
Cantor Fitzgerald started coverage on shares of Asensus Surgical (NYSEAMERICAN:ASXC – Get Rating) in a report issued on Thursday morning, The Fly reports. The brokerage issued an overweight rating and a $1.50 target price on the stock.
Separately, HC Wainwright decreased their target price on shares of Asensus Surgical from $4.00 to $3.00 in a research note on Wednesday, August 10th.
Get Asensus Surgical alerts:Asensus Surgical Stock Performance
ASXC stock opened at $0.54 on Thursday. Asensus Surgical has a one year low of $0.35 and a one year high of $2.31.
Asensus Surgical (NYSEAMERICAN:ASXC – Get Rating) last issued its earnings results on Monday, August 8th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.01. The firm had revenue of $0.99 million during the quarter, compared to analysts' expectations of $1.25 million.Institutional Trading of Asensus Surgical
Hedge funds have recently modified their holdings of the business. Millennium Management LLC boosted its stake in Asensus Surgical by 3,552.4% in the 2nd quarter. Millennium Management LLC now owns 5,040,838 shares of the company's stock worth $2,007,000 after purchasing an additional 4,902,823 shares in the last quarter. Walker Asset Management LLC bought a new position in Asensus Surgical during the 2nd quarter valued at about $138,000. Advisor Group Holdings Inc. lifted its stake in Asensus Surgical by 12.3% during the 1st quarter. Advisor Group Holdings Inc. now owns 279,923 shares of the company's stock valued at $2,090,000 after acquiring an additional 30,676 shares during the period. AQR Capital Management LLC bought a new position in Asensus Surgical during the 2nd quarter valued at about $106,000. Finally, GSA Capital Partners LLP bought a new position in Asensus Surgical during the 1st quarter valued at about $138,000.
About Asensus Surgical
(Get Rating)
Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery.
Featured Articles
- Get a free copy of the StockNews.com research report on Asensus Surgical (ASXC)
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
- Are These Green Energy Companies Right For Your Portfolio?
- When Will the Hangover Finally Be Over for Seagate Technology?
- Does Enphase Energy Have the Juice to Keep Powering Higher?
- The One Hydrogen Fuel Cell Stock To Rule Them All
Receive News & Ratings for Asensus Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asensus Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
Cantor Fitzgerald started coverage on shares of Asensus Surgical (NYSEAMERICAN:ASXC – Get Rating) in a report issued on Thursday morning, The Fly reports. The brokerage issued an overweight rating and a $1.50 target price on the stock.
据The Fly报道，康托·菲茨杰拉德在周四上午发布的一份报告中开始报道Ascount Surgical(NYSEAMERICAN：ASXC-GET Rating)的股票。该经纪公司对该股发布了增持评级和1.50美元的目标价。
Separately, HC Wainwright decreased their target price on shares of Asensus Surgical from $4.00 to $3.00 in a research note on Wednesday, August 10th.
另外，在8月10日星期三的一份研究报告中，HC Wainwright将Ascount Surgical的目标股价从4.00美元下调至3.00美元。
Asensus Surgical Stock Performance
Ascount外科类股表现
ASXC stock opened at $0.54 on Thursday. Asensus Surgical has a one year low of $0.35 and a one year high of $2.31.
周四，ASXC股价开盘报0.54美元。Ascount Surgical的一年低点为0.35美元，一年高位为2.31美元。
Institutional Trading of Asensus Surgical
资产评估外科的机构交易
Hedge funds have recently modified their holdings of the business. Millennium Management LLC boosted its stake in Asensus Surgical by 3,552.4% in the 2nd quarter. Millennium Management LLC now owns 5,040,838 shares of the company's stock worth $2,007,000 after purchasing an additional 4,902,823 shares in the last quarter. Walker Asset Management LLC bought a new position in Asensus Surgical during the 2nd quarter valued at about $138,000. Advisor Group Holdings Inc. lifted its stake in Asensus Surgical by 12.3% during the 1st quarter. Advisor Group Holdings Inc. now owns 279,923 shares of the company's stock valued at $2,090,000 after acquiring an additional 30,676 shares during the period. AQR Capital Management LLC bought a new position in Asensus Surgical during the 2nd quarter valued at about $106,000. Finally, GSA Capital Partners LLP bought a new position in Asensus Surgical during the 1st quarter valued at about $138,000.
对冲基金最近调整了对该业务的持股。千禧管理有限责任公司在第二季度将其在Ascount Surgical的持股增加了3552.4%。Millennium Management LLC在上个季度又购买了4,902,823股后，现在拥有5,040,838股该公司股票，价值2,007,000美元。Walker Asset Management LLC在第二季度购买了Ascount Surgical的一个新头寸，价值约13.8万美元。Advisor Group Holdings Inc.在第一季度增持了Ascount Surgical 12.3%的股份。Advisor Group Holdings Inc.在此期间增持了30,676股，目前持有279,923股该公司股票，价值2,090,000美元。AQR Capital Management LLC在第二季度购买了Ascount Surgical的一个新头寸，价值约10.6万美元。最后，GSA Capital Partners LLP在第一季度购买了Ascount Surgical的一个新头寸，价值约13.8万美元。
About Asensus Surgical
关于Ascount Surgical
(Get Rating)
(获取评级)
Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery.
Ascount Surgical，Inc.是一家医疗设备公司，从事医疗设备机器人的研究、开发和销售，以增强美国、欧洲和亚洲的微创手术(MIS)。它将外科医生和患者之间的接口数字化，通过为外科医生释放临床智能来开创性能指导手术的新时代，以实现始终如一的卓越结果和新的手术标准。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Asensus Surgical (ASXC)
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
- Are These Green Energy Companies Right For Your Portfolio?
- When Will the Hangover Finally Be Over for Seagate Technology?
- Does Enphase Energy Have the Juice to Keep Powering Higher?
- The One Hydrogen Fuel Cell Stock To Rule Them All
- 免费获取StockNews.com关于Ascount Surgical(ASXC)的研究报告
- 石油和天然气股票：投资可再生能源的安全途径
- 这些绿色能源公司适合你的投资组合吗？
- 希捷科技的宿醉何时才能结束？
- 安相能源有足够的动力继续提高动力吗？
- 独一无二的氢燃料电池库存
Receive News & Ratings for Asensus Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asensus Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
接收《评估外科日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Ascount Surgical及相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧